Target intelligence / Profile preview

HLA complex group 20 (non-protein coding RNA) (HCG20)

Target
HCG20
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

HLA complex group 20 (HCG20) is a human gene that encodes a **long non-coding RNA (lncRNA)** rather than a protein and is annotated as a non-coding RNA locus within the major histocompatibility complex (MHC) region of chromosome 6[7]. LncRNAs are generally involved in the regulation of gene expression at the transcriptional or post-transcriptional level, chromatin remodeling, and sometimes the modulation of neighboring gene loci[2][6]. However, there are currently **no data supporting a direct biological function, disease association, drug interaction, or established therapeutic relevance** for HCG20 specifically. This locus is not considered a protein-coding target, receptor, enzyme, transporter, or other established molecular therapeutic target. The entry is often confused with HLA protein-coding genes, but HCG20 is specifically a non-protein-coding RNA and should not be considered a therapeutic target such as a receptor or enzyme[7]. No disease role, interacting drugs, mechanism of action, or biomarker usage has been described for HCG20 as of current genomic annotation. “HLA complex group 20” or “HCG20” should not be confused with HLA class I or II genes, which encode antigen-presenting proteins[1][3][5]. If you require data for HLA receptors or protein-coding members of the HLA region, HCG20 is not appropriate.

Other names
AB023051.1NCRNA00149non-protein coding RNA 149
02

Biological functions

Likely gene regulation (general lncRNA functions)chromatin remodelingepigenetic regulationtranscriptional modulation
03

Disease associations

Unknown/Other

Beyond the preview

Go deeper on HLA complex group 20 (non-protein coding RNA) (HCG20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HLA complex group 20 (non-protein coding RNA) (HCG20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call